These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 11236211

  • 1. The development of antibiotic resistance in Propionibacterium acnes.
    Leyden J, Levy S.
    Cutis; 2001 Feb; 67(2 Suppl):21-4. PubMed ID: 11236211
    [Abstract] [Full Text] [Related]

  • 2. Effect of topical benzoyl peroxide/clindamycin versus topical clindamycin and vehicle in the reduction of Propionibacterium acnes.
    Leyden JJ.
    Cutis; 2002 Jun; 69(6):475-80. PubMed ID: 12078851
    [Abstract] [Full Text] [Related]

  • 3. Comparative efficacy of clindamycin and benzoyl peroxide for in vivo suppression of Propionibacterium acnes.
    Gans EH, Kligman AM.
    J Dermatolog Treat; 2002 Sep; 13(3):107-10. PubMed ID: 12227872
    [Abstract] [Full Text] [Related]

  • 4. The combination formulation of clindamycin 1% plus benzoyl peroxide 5% versus 3 different formulations of topical clindamycin alone in the reduction of Propionibacterium acnes. An in vivo comparative study.
    Leyden J, Kaidbey K, Levy SF.
    Am J Clin Dermatol; 2001 Sep; 2(4):263-6. PubMed ID: 11705253
    [Abstract] [Full Text] [Related]

  • 5. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris.
    Cunliffe WJ, Holland KT, Bojar R, Levy SF.
    Clin Ther; 2002 Jul; 24(7):1117-33. PubMed ID: 12182256
    [Abstract] [Full Text] [Related]

  • 6. Antibiotic-resistant Propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6%.
    Leyden JJ, Wortzman M, Baldwin EK.
    Cutis; 2008 Dec; 82(6):417-21. PubMed ID: 19181031
    [Abstract] [Full Text] [Related]

  • 7. Community-based trial results of combination clindamycin 1%--benzoyl peroxide 5% topical gel plus tretinoin microsphere gel 0.04% or 0.1% or adapalene gel 0.1% in the treatment of moderate to severe acne.
    Kircik L.
    Cutis; 2007 Jul; 80(1 Suppl):10-4. PubMed ID: 17824581
    [Abstract] [Full Text] [Related]

  • 8. Antibiotic resistance in the topical treatment of acne vulgaris.
    Leyden JJ.
    Cutis; 2004 Jun; 73(6 Suppl):6-10. PubMed ID: 15228128
    [Abstract] [Full Text] [Related]

  • 9. In vivo antibacterial effects of tretinoin-clindamycin and clindamycin alone on Propionibacterium acnes with varying clindamycin minimum inhibitory.
    Leyden JJ.
    J Drugs Dermatol; 2012 Dec; 11(12):1434-8. PubMed ID: 23377513
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and Safety of VB-1953 Topical Gel in Non-Responder Acne Patients with Clindamycin-Resistant Cutibacterium acnes.
    Batra R, Sadhasivam S, Saini S, Gupta S, Bisen RKS, Sinha M, Ghosh S, Jain S.
    Drugs R D; 2020 Jun; 20(2):95-104. PubMed ID: 32222937
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of kaempferol isolated from the Impatiens balsamina alone and in combination with erythromycin or clindamycin against Propionibacterium acnes.
    Lim YH, Kim IH, Seo JJ.
    J Microbiol; 2007 Oct; 45(5):473-7. PubMed ID: 17978809
    [Abstract] [Full Text] [Related]

  • 12. Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris.
    Dhawan SS.
    Cutis; 2009 May; 83(5):265-72. PubMed ID: 19537284
    [Abstract] [Full Text] [Related]

  • 13. The impact and importance of resistance.
    Tanghetti E.
    Cutis; 2007 Jul; 80(1 Suppl):5-9. PubMed ID: 17824580
    [Abstract] [Full Text] [Related]

  • 14. [Treating acne: avoid the development of antibiotic resistance by applying topical and combined therapy].
    Abeck D.
    MMW Fortschr Med; 2003 Dec 18; 145(51-52):29. PubMed ID: 14974325
    [No Abstract] [Full Text] [Related]

  • 15. In-vivo Effectiveness of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel on Antibiotic-sensitive and Resistant Propionibacterium acnes.
    Leyden JJ, Preston N, Osborn C, Gottschalk RW.
    J Clin Aesthet Dermatol; 2011 May 18; 4(5):22-6. PubMed ID: 21607190
    [Abstract] [Full Text] [Related]

  • 16. Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris.
    Draelos ZD, Potts A, Alió Saenz AB, W0265-306 Study Group.
    Cutis; 2010 Dec 18; 86(6):310-8. PubMed ID: 21284283
    [Abstract] [Full Text] [Related]

  • 17. A new treatment for acne vulgaris combining benzoyl peroxide with clindamycin.
    Tschen E, Jones T.
    J Drugs Dermatol; 2002 Sep 18; 1(2):153-7. PubMed ID: 12847739
    [Abstract] [Full Text] [Related]

  • 18. Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and -resistant skin bacteria from acne patients.
    Eady EA, Farmery MR, Ross JI, Cove JH, Cunliffe WJ.
    Br J Dermatol; 1994 Sep 18; 131(3):331-6. PubMed ID: 7918006
    [Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
    Eichenfield LF, Alió Sáenz AB.
    J Drugs Dermatol; 2011 Dec 18; 10(12):1382-96. PubMed ID: 22134562
    [Abstract] [Full Text] [Related]

  • 20. The effect of benzoyl peroxide 9.8% emollient foam on reduction of Propionibacterium acnes on the back using a short contact therapy approach.
    Leyden JJ, Del Rosso JQ.
    J Drugs Dermatol; 2012 Jul 18; 11(7):830-3. PubMed ID: 22777224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.